J0695 HCPCS Level II Code: Injection, ceftolozane 50 mg and tazobactam 25 mg
Coding at a Glance
- Drug products
- 1 NDC product
- CMS cross-references
- 1 related code
Medicare Coverage & Payment
- CMS short descriptor: Inj ceftolozane tazobactam
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2016
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Related Codes
CMS cross-reference from deleted or non-Medicare codes
The CMS HCPCS Level II code set cross-references these codes (deleted or not valid for Medicare) to this code.
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q3
Medicare Part B payment limit (ASP + 6%): $10.04
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J0695 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- J0608 — Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)[Sibling]
- J0609 — Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)[Sibling]
- J0610 — Injection, calcium gluconate (fresenius kabi), per 10 ml[Sibling]
- J0611 — Injection, calcium gluconate (wg critical care), per 10 ml[Sibling]
- J0612 — Injection, calcium gluconate, not otherwise specified, 10 mg[Sibling]
- J0613 — Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg[Sibling]
- J0614 — Injection, treosulfan, 50 mg[Sibling]
- J0615 — Calcium acetate, oral, 23 mg (for esrd on dialysis)[Sibling]
- and 32 more
CMS cross-reference
- C9452 — Injection, ceftolozane 50 mg and tazobactam 25 mg[Cross-referenced from]
Change history
- January 1, 2016 — Added to the code set [Change history]
Sources for this page
Every coding fact on this page is read from the datasets below. Nothing is AI-generated; MedCoder-derived relationships and editorial are labelled where they appear.
- Code, descriptors, coverage and pricing attributes
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update
- Drug products
- CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release); FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24
- Change history and date-of-service validity
- CMS HCPCS quarterly update files, ingested into the change ledger
- Comparisons, relationships and the contextual map MedCoder-derived
- Derived by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
Change history
- January 1, 2016Added to the code setInjection, ceftolozane 50 mg and tazobactam 25 mg
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0695 in its code family, with their registry titles.
- J0689 — Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
- J0690 — Injection, cefazolin sodium, 500 mg
- J0691 — Injection, lefamulin, 1 mg
- J0692 — Injection, cefepime hydrochloride, 500 mg
- J0693 — Injection, cefiderocol, 5 mg
- J0694 — Injection, cefoxitin sodium, 1 gm
- J0696 — Injection, ceftriaxone sodium, per 250 mg
- J0697 — Injection, sterile cefuroxime sodium, per 750 mg
- J0698 — Injection, cefotaxime sodium, per gm
- J0699 — Injection, cefiderocol, 10 mg